Novo Nordisk a/S Compound

DB02662ExperimentalSmall molecule

Novo Nordisk a/S Compound: Overview.

Mechanism: Pharmacologically active on Tyrosine-protein phosphatase non-receptor type 1
Curator reviewed
Formula / weight: C₉H₆INO₅ · 335.0521 g/mol (avg)

Resolves to

Compound

Structure

InChIKeySHSWHSQPJKMCPN-UHFFFAOYSA-NSMILESOC(=O)C(=O)NC1=C(C=C(I)C=C1)C(O)=O

Targets

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Novo Nordisk a/S Compound, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.